Clinical trial
Observational Prospective Study on Patients With Symptomatic Uterine Fibroids Treated With VizAblate® Intrauterine-ultrasound Guided RF Ablation
NCT01998854 is registered in ClinicalTrials.gov with Gynesonics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Observational Prospective Study on Patients With Symptomatic Uterine Fibroids Treated With VizAblate® Intrauterine-ultrasound Guided RF Ablation
- Lead sponsor
- Gynesonics
- Phase
- Observational
- Overall status
- Terminated
- Start date
- February 28, 2013
- Completion date
- January 31, 2015
- Enrollment
- 4 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
leiomyoma, menorrhagia, uterine fibroids, uterine fibroma, uterine neoplasms